Literature DB >> 2751477

Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women.

J P Després1, M Ferland, S Moorjani, A Nadeau, A Tremblay, P J Lupien, G Thériault, C Bouchard.   

Abstract

Intra-abdominal fat content is an important variable in the association between regional body fat distribution and plasma high density lipoprotein (HDL) cholesterol levels. In the present study, we report on the role of plasma postheparin lipases as well as abdominal and femoral adipose tissue lipoprotein lipase activities in the association between body fat distribution and plasma lipoprotein levels. Postheparin plasma lipoprotein lipase (LPL), hepatic-triglyceride lipase (H-TGL), abdominal and femoral adipose tissue (AT)-LPL activities and plasma lipoprotein levels were measured after an overnight fast in a sample of 16 obese women (ages 36.0 +/- 6.1 years [mean +/- SD], percent body fat 46% +/- 6%). Computed axial tomography was used to assess body fat distribution. Plasma postheparin LPL activity was neither correlated with total adiposity nor with the level of intra-abdominal fat. Intra-abdominal fat deposition was, however, positively correlated with H-TGL activity (r = 0.66, p less than 0.005). Furthermore, covariance analysis showed that the association between intra-abdominal fat and H-TGL was independent from total adiposity. Plasma postheparin LPL and abdominal AT-LPL activities showed no significant correlation with plasma lipoprotein levels, whereas femoral AT-LPL activity was positively correlated with the HDL2 cholesterol/HDL3 cholesterol ratio (r = 0.51, p less than 0.05). H-TGL activity was, however, negatively correlated with HDL2 cholesterol (r = -0.60, p less than 0.05), but not with HDL3 cholesterol (r = -0.28, NS). These results suggest that the high H-TGL activity in obese women with excess deep abdominal fat could be responsible for the reduction in plasma HDL2 cholesterol levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751477     DOI: 10.1161/01.atv.9.4.485

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  22 in total

1.  Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity.

Authors:  Verónica Miksztowicz; Laura Schreier; Mary McCoy; Diego Lucero; Eduardo Fassio; Jeffrey Billheimer; Daniel J Rader; Gabriela Berg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-01-23       Impact factor: 8.311

Review 2.  The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype.

Authors:  John D Brunzell; Alberto Zambon; Samir S Deeb
Journal:  Biochim Biophys Acta       Date:  2011-09-25

3.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

Authors:  M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn
Journal:  Diabetologia       Date:  2003-04-10       Impact factor: 10.122

4.  Differential Effects of Continuous and Interval Exercise Training on the Atherogenic Index of Plasma in the Non-Obese Young Male.

Authors:  Antoninus O Ezeukwu; Elias O Agwubike; Patrick O Uadia
Journal:  Acta Cardiol Sin       Date:  2015-07       Impact factor: 2.672

5.  Abundant daily non-sedentary activity is associated with reduced prevalence of metabolic syndrome and insulin resistance.

Authors:  H Uemura; S Katsuura-Kamano; M Yamaguchi; M Nakamoto; M Hiyoshi; K Arisawa
Journal:  J Endocrinol Invest       Date:  2013-07-26       Impact factor: 4.256

6.  Identification of four chromosomal loci determining obesity in a multifactorial mouse model.

Authors:  C H Warden; J S Fisler; S M Shoemaker; P Z Wen; K L Svenson; M J Pace; A J Lusis
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Mice lacking hepatic lipase are lean and protected against diet-induced obesity and hepatic steatosis.

Authors:  Harvey K Chiu; Kun Qian; Kayoko Ogimoto; Gregory J Morton; Brent E Wisse; Nalini Agrawal; Thomas O McDonald; Michael W Schwartz; Helén L Dichek
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

8.  Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size.

Authors:  Serena M Pratt; Sally Chiu; Glenda M Espinal; Noreene M Shibata; Howard Wong; Craig H Warden
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

9.  Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study.

Authors:  Omer T Njajou; Alka M Kanaya; Paul Holvoet; Stephanie Connelly; Elsa S Strotmeyer; Tamara B Harris; Steve R Cummings; Wen-Chi Hsueh
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

10.  HDL composition regulates displacement of cell surface-bound hepatic lipase.

Authors:  Naghmeh Rouhani; Elizabeth Young; Cynthia Chatterjee; Daniel L Sparks
Journal:  Lipids       Date:  2008-08-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.